Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Update

Raia Drogasil S.A. (OTCMKTS:RADLYGet Free Report) saw a large drop in short interest in May. As of May 15th, there was short interest totaling 478 shares, a drop of 53.7% from the April 30th total of 1,032 shares. Based on an average daily volume of 11,859 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

Raia Drogasil Trading Up 1.7%

Shares of OTCMKTS RADLY traded up $0.06 during mid-day trading on Tuesday, reaching $3.67. 1,688 shares of the company’s stock were exchanged, compared to its average volume of 20,564. Raia Drogasil has a 52 week low of $2.17 and a 52 week high of $5.34. The firm has a 50-day moving average price of $4.34 and a two-hundred day moving average price of $4.52.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

View Our Latest Stock Analysis on RADLY

Raia Drogasil Company Profile

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

Featured Stories

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.